Literature DB >> 8845917

Evaluation of the pro-oxidant and antioxidant actions of L-DOPA and dopamine in vitro: implications for Parkinson's disease.

J P Spencer1, A Jenner, J Butler, O I Aruoma, D T Dexter, P Jenner, B Halliwell.   

Abstract

The antioxidant and pro-oxidant properties of L-DOPA and dopamine were investigated in vitro. Both compounds inhibited the peroxidation of ox-brain phospholipids, with IC50 values of 8.5 microM for dopamine and 450 microM for L-DOPA. Dopamine and L-DOPA reacted with trichloromethyl peroxyl radicals (CCl3O2.) with rate constants of 2.1 x 10(7)M-1s-1 and 1.3 x 10(7)M-1s-1 respectively. The effects of dopamine and L-DOPA on iron ion-dependent hydroxyl radical generation from H2O2 were complex. In general, low concentrations stimulated OH. formation in the presence of ferric-EDTA and, in the case of L-DOPA, ferric-ADP and ferric citrate chelates. Both compounds also reacted with superoxide radical and hypochlorous acid. The products of the reaction with HOCl could still inhibit alpha 1-antiproteinase and appear to be 'long lived' chloramine-type oxidizing species. Our results suggest that L-DOPA and dopamine might have a complex mixture of pro- and anti- oxidant effects, which could contribute to tissue damage due to oxidative stress in Parkinson's disease and other neurological disorders.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8845917     DOI: 10.3109/10715769609088005

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  27 in total

Review 1.  The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

2.  Parkinson disease: the controversy of levodopa toxicity in Parkinson disease.

Authors:  Theresa A Zesiewicz
Journal:  Nat Rev Neurol       Date:  2011-12-26       Impact factor: 42.937

3.  Modulation of brain mitochondrial membrane permeability and synaptosomal Ca2+ transport by dopamine oxidation.

Authors:  K J Kim; Y Y Jang; E S Han; C S Lee
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

4.  Cypermethrin-induced nigrostriatal dopaminergic neurodegeneration alters the mitochondrial function: a proteomics study.

Authors:  Sonal Agrawal; Ashish Singh; Pratibha Tripathi; Manisha Mishra; Pradhyumna Kumar Singh; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2014-04-24       Impact factor: 5.590

Review 5.  S-glutathionylation: from molecular mechanisms to health outcomes.

Authors:  Ying Xiong; Joachim D Uys; Kenneth D Tew; Danyelle M Townsend
Journal:  Antioxid Redox Signal       Date:  2011-05-25       Impact factor: 8.401

6.  Levodopa deactivates enzymes that regulate thiol-disulfide homeostasis and promotes neuronal cell death: implications for therapy of Parkinson's disease.

Authors:  Elizabeth A Sabens; Anne M Distler; John J Mieyal
Journal:  Biochemistry       Date:  2010-03-30       Impact factor: 3.162

Review 7.  Levodopa in Parkinson's disease: neurotoxicity issue laid to rest?

Authors:  M G Murer; R Raisman-Vozari; O Gershanik
Journal:  Drug Saf       Date:  1999-11       Impact factor: 5.606

8.  The allelochemical L-DOPA increases melanin production and reduces reactive oxygen species in soybean roots.

Authors:  Anderson Ricardo Soares; Maria de Lourdes Lucio Ferrarese; Rita de Cássia Siqueira-Soares; Rogério Marchiosi; Aline Finger-Teixeira; Osvaldo Ferrarese-Filho
Journal:  J Chem Ecol       Date:  2011-06-28       Impact factor: 2.626

9.  The effects of dopamine on antioxidant enzymes activities and reactive oxygen species levels in soybean roots.

Authors:  Bruno Ribeiro Gomes; Rita de Cássia Siqueira-Soares; Wanderley Dantas Dos Santos; Rogério Marchiosi; Anderson Ricardo Soares; Osvaldo Ferrarese-Filho
Journal:  Plant Signal Behav       Date:  2014

Review 10.  Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease.

Authors:  Masato Asanuma; Ikuko Miyazaki; Norio Ogawa
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.